Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
BJU International|February 13, 2010
The presence of prostate cancer on saturation biopsy can be accurately predictedSascha A Ahyai, Hendrik Isbarn, Pierre I Karakiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
BJU International|March 5, 2014
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European studyNicola Fossati, Massimo Lazzeri, Alexander Haese, et al.
European Urology|February 5, 2013
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European studyMassimo Lazzeri, Alexander Haese, Alexandre de la Taille, et al.
European Urology|January 14, 2014
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutionsNazareno Suardi, Alessandro Larcher, Alexander Haese, et al.
European Urology|January 4, 2022
Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional CohortMatthew B Clements, Emily A Vertosick, Lourdes Guerrios-Rivera, et al.
European Urology|July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsyAlexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
BJU International|February 13, 2010
The presence of prostate cancer on saturation biopsy can be accurately predictedSascha A Ahyai, Hendrik Isbarn, Pierre I Karakiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
BJU International|March 5, 2014
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European studyNicola Fossati, Massimo Lazzeri, Alexander Haese, et al.
European Urology|February 5, 2013
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European studyMassimo Lazzeri, Alexander Haese, Alexandre de la Taille, et al.
European Urology|January 14, 2014
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutionsNazareno Suardi, Alessandro Larcher, Alexander Haese, et al.
European Urology|January 4, 2022
Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional CohortMatthew B Clements, Emily A Vertosick, Lourdes Guerrios-Rivera, et al.
European Urology|July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsyAlexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.
Pageof 22